Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

J. K. Hicks, K. Sangkuhl, J. J. Swen, V. L. Ellingrod, D. J. Müller, K. Shimoda, J. R. Bishop, E. D. Kharasch, T. C. Skaar, A. Gaedigk, H. M. Dunnenberger, T. E. Klein, K. E. Caudle, J. C. Stingl

Research output: Contribution to journalArticle

119 Scopus citations
Original languageEnglish (US)
Pages (from-to)37-44
Number of pages8
JournalClinical Pharmacology and Therapeutics
Volume102
Issue number1
DOIs
StatePublished - Jul 1 2017

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Hicks, J. K., Sangkuhl, K., Swen, J. J., Ellingrod, V. L., Müller, D. J., Shimoda, K., Bishop, J. R., Kharasch, E. D., Skaar, T. C., Gaedigk, A., Dunnenberger, H. M., Klein, T. E., Caudle, K. E., & Stingl, J. C. (2017). Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update. Clinical Pharmacology and Therapeutics, 102(1), 37-44. https://doi.org/10.1002/cpt.597